Jiangsu Delfu medical device Co.,Ltd

Jiangsu Delfu medical device Co.,Ltd(Delfu Medical),  is an innovative leading Chinese manufacturer and supplier, engages in research, manufacturing, marketing and sales medical devices, offers diagnosis, analysis, monitoring and treatment medical equipments for diabetes and cardiac patients. We focus on products of series Insulin injection pen, insulin pumps, continuous glucose monitoring systems, personal wireless real-time ECG monitors, etc. Especially we have made the name of injection pen with its full series and unique design in China, including electronic syringe, auto pen, smart insulin pen, prefilled insulin pen, needle hidden HGH injection pen, metal and plastic manual injection pen.Delfu Medical brings the revolutionary technology for its continuous developing, with its 20 years supplying quality products,credibility and efficient services, has been recognized and trusted by domestic and international clients. Covers around 800,000 floor areas totally in two manufacturing locations with advanced facilities and equipment. We keep 20%~30% growing by bringing credit to management, staff and our products. Delfu Medical cooperates with 5 China top-ranking universities, including Nanjing University, South-East University in regard to product research and support for sustainable development. we hold intellectual property rights of 6 invention patents and a number of utility patents.Delfu Medical is looking for oversea medical devices partner of pharmaceutical manufacturer, distributors, traders and agents, which is diabetic and cardiac patients product related. We also welcome OEM/ODM cooperation and solution for any unique and beneficial product.Delfu Medical upholds the mission of improving life quality of diabetes and cardiac patients, exercises and affords the utmost social responsibility at all time, provides most safe, reliable, high- performance medical devices at competitive prices. we are committed to help world wide clients develop profitable relationships from China.